In this episode we take listener questions on the upcoming US elections and US Cannabis in general.

In this episode:

1. Kamala Harris and the uncertainty of Timing

2. Will the US Decriminalize or Legalize? What’s the difference?

3. Will the FDA get involved in THC regulation like they did with CBD?

4. Do we have data to support the thesis that NASDAQ-listed weed stocks can outperform?

5. Low Volume Weed Stocks – should they be avoided? Why might they be a good opportunity?

6. Will the US eventually become like Canada as more capital flows in? Why or why not?

7. How will SAFE Banking affect Cannabis REITs?

8. What is the best Cannabis beverage so far and when will it come to the US?

9. Which players will benefit the most from coming state legalizations?

10. “Don’t sell the winners; come back in a few years” – why not buy and hold instead of trading?

11. Will Weed Stocks bubble then crash (similar to 2018) with the coming US Election?

12. Thoughts on options trading in Cannabis?

13. Which Fortune 500 companies do you see jumping into Cannabis?

14. What is the biggest risk to cash flows for US MSOs?

15. What is going on “behind the scenes” that investors should be aware of?

16. Which MSO would benefit the most from a Biden win or a “blue wave”?

17. Which MSO is the most undervalued?

Thanks to pmitch, Ankur, BuildSoc, Airick-The-Great, SongWriter, Opposite Day, Alderho10 & Zebah for the questions!

A few months ago we discussed Cannabis trading ideas around the US Presidential Election - now with under 30 days to go until the big day we revisit the names we find interesting and our related strategies. The theme of today's episode is "sometimes things get complicated".

- How Trump hitting pause on stimulus talks could hurt weed stocks

- Reflecting on how the market has recovered since the March lows 

- How the upcoming election might cause an extreme outcome and civil unrest

- Why the ballot initiatives in AZ and NJ are such a big deal - and which one matters more

- 4 Nasdaq listed names that have the potential to heat up: Grow Gen, IIPR, Greenlane & Scots Miracle Grow

- Which of these 4 we like the most and why

- The Big 4 MSOs - how are they positioned going into the election and into 2021?

- Demanding a margin of safety in your cannabis investments to hedge your risk

In this episode we try to understand - why is Canada such a mess? Are we approaching an inflection point where things change? Is there a buying opportunity in Canada? 

1. Who Cares? Why investors should pay attention to Canada

2. What Happened? How did we get here

3. Why did it happen?

4. Where are now?

5. Where are we headed?

6. Is it a buying opportunity?

7. What areas or indicators are we watching?

**Note: audio quality is a little funky as we adjust to the new studio but gets better after the 5 min mark; we will improve on the next one!

In this episode we delve into the concept of risk adjusted return when investing in cannabis:

- What is Risk? 

- How do we measure and think about risk?

- What risks are specific to the Cannabis industry that investors need to watch out for?

- Why is it so important to think about risk in this industry

- Why valuation is one of the most important things to investors

- Trulieve's PA Acquisitions - how do risk and return play into making this decision

- How should investors think about potential return?

- Balancing risk and return in your cannabis portfolio

- Examining names like Liberty Health, Trulieve and Ianthus in terms of risk vs reward

In this episode we explore the benefits and challenges of chasing momentum or seeking value in the cannabis industry. 

Topics:

1. Momentum Investing

- What is it?

- How do we find momentum opportunities 

- How does it apply to the cannabis space and why does it matter

2. Value Investing

- What is it?

- What makes a good value investment

- Examples of cannabis investments which are value oriented (LHS & Vireo)

- Pitfalls of value investing

3. Momentum vs Value

- What should investors look at in cannabis

- Why the big 4 MSOs might experience superior growth

- How capital raising creates a competitive advantage

- Cannabis vs Tech and "winner take all"

4. Our Strategies

- Investment decisions made in 2020

- Private vs Public investments

- US Election in Nov - which stocks we've purchased to try to ride the momentum

In this episode we are joined by Nick Gastevich who is known on the forums as CannaVestments. He is known for deep cannabis knowledge, a keen analytical eye and being an all-around nice guy.

Nick runs a family office along with his brother - they started in the industry in 2014 with an investment in Green Thumb. He joins us on this episode to do a deep dive on the "Green Chip" cannabis names which have captured investor attention lately.

In this episode we review:

1. Green Thumb (GTI) 

2. Trulieve

3. Cresco Labs

4. Curaleaf

For each company we review

- Footprint of each company 

- Key markets for each company (now and in the future)

- Which markets and assets are the most exciting

- Q2 Financials - Revenue, Gross Margins & Adjusted EBITDA

- 2020 & 2021 Earnings Multiples

- Valuations of each company: now and in the future

- Ranking of the big 4 at current prices

Note: This episode was recorded a few weeks ago, since then Florida has legalized edibles

In this week's episode we are joined by Alan Brochstein of 420investor (https://marketfy.com/product/420investor/) and New Cannabis Ventures (https://www.newcannabisventures.com/).

Alan (aka "The Maven") is one of the leading providers of original thought and analysis in the cannabis space. He runs 3 cannabis-only model portfolios on 420i and he joins us to talk about his investing philosophy as well as how things are changing since he started in 2014.

Topics Covered:

- Intro to Alan, 420i and New Cannabis Ventures

- The Three Waves of Cannabis Investing since 2012

- How Alan called a Cannabis Bull Market in May 2020

- "This Time is Different" for Cannabis Companies

- The one time Alan moved to all cash in his model portfolio

- "How the Market works" with a live example

- Technical vs Fundamental Investing (or Momentum vs Value)

- Mistakes Made & Timing the Market

- The new MSOS ETF by AdvisorShares 

- How will this NASDAQ listed ETF affect weed stocks?

- How Investors may be able to "Front-run" the MSOS ETF

- Investing for the 2020 Election - Risks and Catalysts

- Inefficiencies in Cannabis presents great opportunity for Investors

- The Big 4 MSOs Potentially Evolving to the Top 10

- The Most Common Mistake Investors Make

- Is a Mass Extinction Event still in the works?

Thanks to Alan - this is an insight packed episode!

In this episode we do a 2020 update to our "How to Invest in Weed Stocks" episode from 2019. A lot has changed in the year since and it's important to upgrade your game accordingly! We discuss how things have changed and the mindset you should have going forward.

In this episode:

1. Understanding Risk in Cannabis Investing

2. What you should learn about 

3. Advantages of learning

4. Understanding the cannabis business

5.  Deciding to Invest - Questions to answer before Pulling the Trigger

6. Trading vs Investing in Cannabis

In this episode we have our first guest ever! Alex Gastevich runs a family office along with his brother and mother. Based out of Chicago the Gastevich family were early round investors in GTI in 2014. Alex joins us to discuss:

- Investing in early round Cannabis companies (GTI and Medipharm)

- The value of having multiple perspectives in investing decisions

- What's the craziest thing you've seen in the cannabis space?

- What makes a cannabis company successful?

- What are signs of being in a cannabis bubble?

- What's the biggest lost you've taken in this industry?

- What's your end game?

This was a very fun episode, thanks to Alex for joining us!

In this week's episode we answer questions regarding the amazing performance of the large MSOs:

- Are US MSOs better than the Canadian LPs? 

- Why are they out performing?

- Why the US is a better place for the cannabis sector

- What makes a market successful for cannabis companies (Canada, California, Oregon vs Illinois, Florida & NJ)

- Canopy vs GTI vs Trulieve

- Are the US companies over priced?

- Are the Canadian names priced for value?

- The power of the NASDAQ listing

- A word of caution on chasing momentum